Kidney Cancer: Incidental Findings, Symptoms, and Treatment Choices

Kidney cancer is increasingly found by chance during imaging tests performed for other reasons, often before it causes symptoms. Treatment is individualized according to the tumor size, stage, kidney function, overall health, and patient preferences.

Overview

Kidney cancer begins when cells in the kidney grow in an uncontrolled way and form a tumor. The most common type in adults is renal cell carcinoma, which has several subtypes. Less common kidney tumors include urothelial cancer of the renal pelvis, Wilms tumor in children, and rare benign or malignant masses. Because the kidneys sit deep in the back of the abdomen, small tumors may not be felt or noticed.

Today, many kidney tumors are discovered incidentally. This means they are found during an ultrasound, CT scan, or MRI performed for another reason, such as abdominal pain, back pain, kidney stones, trauma, or evaluation of another condition. Incidental discovery can be helpful because many tumors are found while still localized to the kidney, when several effective treatment choices may be available.

Not every kidney mass is cancer, and not every kidney cancer behaves the same way. Some small kidney tumors grow slowly, while others require prompt treatment. A careful evaluation by a urologist, oncologist, radiologist, and when needed a nephrologist helps determine the safest and most appropriate plan for each person.

Symptoms and Incidental Findings

Early kidney cancer often causes no symptoms. When symptoms do appear, they can overlap with common non-cancer conditions such as kidney stones, urinary tract infections, muscle strain, or benign prostate problems. For this reason, symptoms should be assessed by a qualified doctor rather than assumed to be cancer.

Possible signs and symptoms may include blood in the urine, which can be visible or detected only on a urine test; pain or pressure in the side or lower back; a lump or fullness in the side; persistent fatigue; unexplained weight loss; fever not related to infection; night sweats; or anemia. Some people develop high blood pressure or abnormal blood test results related to kidney function or calcium levels.

Incidental findings are commonly reported as a “renal mass,” “kidney lesion,” “complex cyst,” or “solid enhancing lesion” on imaging. These terms do not always mean cancer. Simple kidney cysts are very common and usually benign. More detailed imaging may be needed to distinguish a harmless cyst from a tumor that needs monitoring or treatment.

Causes and Risk Factors

In most people, kidney cancer does not have one clear cause. It develops through changes in kidney cells that allow them to multiply and survive when they should not. Researchers have identified several factors that can increase risk, but having a risk factor does not mean a person will develop kidney cancer, and many people diagnosed have no obvious risk factor.

Known risk factors include smoking, obesity, high blood pressure, long-term dialysis, certain inherited syndromes, and a family history of kidney cancer. Some occupational or environmental exposures have also been associated with increased risk. Men are diagnosed more often than women, and risk generally rises with age.

Inherited kidney cancer syndromes are uncommon but important to recognize. They may be suspected when kidney cancer occurs at a young age, affects both kidneys, includes multiple tumors, or appears in several family members. In such situations, genetic counseling and testing may help guide screening and treatment for the patient and possibly relatives.

• Modifiable factors: avoiding tobacco, maintaining a healthy weight, and controlling blood pressure can support overall kidney and cardiovascular health.
• Medical factors: chronic kidney disease, dialysis history, and certain genetic conditions may require specialized follow-up.
• Family factors: a strong family history may warrant discussion with a genetics professional.

Diagnosis and Staging

Diagnosis usually begins with imaging. Ultrasound may identify a mass or cyst, while contrast-enhanced CT or MRI often provides more detail about size, location, blood supply, and whether the tumor appears solid or cystic. MRI may be preferred in some patients, such as those who cannot receive certain CT contrast agents or when more information about blood vessels is needed.

Blood and urine tests help evaluate kidney function, anemia, infection, blood in the urine, and overall health before treatment. If cancer is suspected, additional imaging of the chest, abdomen, or bones may be recommended depending on symptoms and findings. These tests help determine whether the cancer appears confined to the kidney or has spread.

A biopsy is not always required before surgery for a kidney mass, because imaging can sometimes be highly suggestive and removal may be both diagnostic and therapeutic. However, biopsy can be useful when the diagnosis is uncertain, when ablation or active surveillance is being considered, when results may change the treatment plan, or when drug therapy is planned for advanced disease.

Staging describes how far the cancer has progressed. Localized disease is limited to the kidney. Locally advanced disease may involve nearby tissues, large veins, or lymph nodes. Metastatic disease has spread to distant organs such as the lungs, bones, liver, or brain. Staging, tumor grade, subtype, kidney function, and overall health all influence treatment decisions.

Treatment Choices for Localized Kidney Cancer

For kidney cancer that is limited to the kidney, surgery is a common treatment. A partial nephrectomy removes the tumor while preserving as much healthy kidney tissue as possible. This approach is often preferred for small tumors when technically feasible, especially for people with reduced kidney function, a single kidney, tumors in both kidneys, diabetes, or high blood pressure.

A radical nephrectomy removes the entire kidney and surrounding tissue, and sometimes nearby lymph nodes or adrenal tissue if involved. It may be recommended for larger tumors, centrally located tumors, or cases where partial nephrectomy would not safely remove the cancer. Many kidney operations can be performed with minimally invasive techniques, including laparoscopic or robotic-assisted surgery, depending on tumor features and surgical expertise.

For selected small kidney tumors, active surveillance may be appropriate. This means monitoring the tumor with scheduled imaging and clinical review rather than treating immediately. It may be considered for older adults, people with serious medical conditions, or small masses that appear slow growing. Treatment can still be started later if the tumor grows or changes.

Ablation is another option for some small tumors, especially when surgery carries higher risk. Techniques such as cryoablation or radiofrequency ablation use extreme cold or heat to destroy tumor tissue, often through a needle guided by imaging. The choice between surveillance, ablation, and surgery should be made after discussing expected benefits, risks, follow-up needs, and the importance of preserving kidney function.

Treatment for Advanced or Recurrent Kidney Cancer

When kidney cancer has spread beyond the kidney or returns after treatment, care is usually planned by a multidisciplinary team. Treatment may include systemic therapies that travel through the bloodstream, local treatments to control specific areas, or surgery in carefully selected situations. The goal may be to control the disease, reduce symptoms, preserve function, and support quality of life.

Modern systemic treatment for advanced renal cell carcinoma often uses immunotherapy, targeted therapy, or a combination. Immunotherapy helps the immune system recognize and attack cancer cells. Targeted therapies interfere with pathways that tumors use to grow blood vessels or multiply. The best option depends on the cancer subtype, risk category, previous treatments, side effect profile, and the patient’s general health.

Radiation therapy is not usually the main treatment for kidney cancer within the kidney, but it can be useful for symptom relief or control of specific metastases, such as painful bone lesions or certain brain metastases. Surgery to remove the kidney or a metastasis may be considered in selected patients, particularly when disease burden is limited or symptoms need local control.

Clinical trials may provide access to new combinations or approaches under careful medical supervision. Participation is voluntary, and patients should be informed about the purpose of the trial, possible benefits and risks, required visits, and alternatives. Supportive care, including pain control, nutrition, rehabilitation, and emotional support, is an important part of treatment at every stage.

Prevention, Self-Care, and Follow-Up

There is no guaranteed way to prevent kidney cancer, but several healthy habits can reduce risk and protect kidney health. Not smoking is one of the most important steps. Maintaining a healthy weight, staying physically active, eating a balanced diet, limiting excess salt, and controlling blood pressure can also support the kidneys and overall wellbeing.

People who have been treated for kidney cancer need a follow-up plan tailored to tumor stage, type of treatment, kidney function, and risk of recurrence. Follow-up may include physical examinations, blood tests, urine tests, and imaging at scheduled intervals. These visits also help monitor the remaining kidney tissue, manage treatment side effects, and address fatigue, blood pressure, or emotional concerns.

Patients can support recovery by keeping medical appointments, taking prescribed medicines as directed, reporting new symptoms, and asking before using supplements that may affect kidney function or interact with cancer therapies. Staying well hydrated is often helpful, but fluid advice should be individualized for people with heart disease, kidney disease, or other medical conditions.

Emotional wellbeing matters. A kidney cancer diagnosis, even when found early, can create uncertainty. Reliable information, clear communication with the care team, family support, counseling, and patient support groups can help people make decisions with more confidence.

When to See a Doctor

A person should seek medical evaluation for visible blood in the urine, persistent flank or back pain that is not explained, an abdominal or side lump, unexplained weight loss, ongoing fever, unusual fatigue, or abnormal urine or imaging results. Most of these symptoms have causes other than cancer, but checking them promptly allows the right diagnosis and treatment.

Anyone told they have a kidney mass, complex cyst, or suspicious renal lesion should ask what type of imaging was performed, whether contrast imaging is needed, how large the lesion is, and whether referral to a urologist is recommended. It is reasonable to ask about all suitable options, including surveillance, partial nephrectomy, radical nephrectomy, ablation, and biopsy when appropriate.

Urgent medical attention is needed for heavy bleeding in the urine with clots, inability to urinate, severe uncontrolled pain, high fever with urinary symptoms, or sudden weakness or confusion. These situations can have several causes and require timely assessment.

For international patients seeking evaluation, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat kidney cancer using coordinated urology, oncology, radiology, pathology, and supportive care services. Treatment decisions should always be individualized after review by qualified clinicians.

Frequently asked questions

Is an incidental kidney mass always cancer?

No. Many incidental kidney findings are benign cysts or non-cancerous lesions. Imaging features such as whether the mass is solid, cystic, or enhances with contrast help doctors estimate risk. Sometimes follow-up imaging, MRI, or biopsy is needed before deciding on treatment.

What is the most common type of kidney cancer?

The most common type in adults is renal cell carcinoma. It includes several subtypes, such as clear cell, papillary, and chromophobe renal cell carcinoma. Subtype can affect prognosis and treatment choices, especially in advanced disease.

Can kidney cancer be treated without removing the whole kidney?

Yes, in many cases. Partial nephrectomy removes only the tumor and a margin of tissue, preserving the rest of the kidney. For selected small tumors, ablation or active surveillance may also be appropriate.

When is active surveillance considered for kidney cancer?

Active surveillance may be considered for small kidney masses, especially if they appear slow growing or if a person has other health conditions that make immediate treatment less desirable. It involves scheduled imaging and clinical review. If the tumor grows or changes, treatment can be reconsidered.

Does blood in the urine mean kidney cancer?

Blood in the urine does not always mean cancer. It can be caused by urinary tract infection, kidney stones, prostate conditions, medications, or other kidney diseases. However, visible blood in the urine should be evaluated by a doctor to identify the cause.

What treatments are used if kidney cancer has spread?

Advanced kidney cancer may be treated with immunotherapy, targeted therapy, or combinations of these medicines. Radiation, surgery, or other local treatments may be used for specific symptoms or limited areas of disease. The plan depends on the cancer subtype, extent of spread, general health, and previous treatment.

References

• European Association of Urology
• National Comprehensive Cancer Network
• American Cancer Society
• National Cancer Institute
• European Society for Medical Oncology

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.